Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials

Author(s):
Nout, R.A.; Peters, E.E.M.; Jurgenlienik-Schulz, I.M.; Jobsen, J.J.; Mens, J.W.M.; Stelloo, E.; Smit, V.T.H.; Bosse, T.; Creutzberg, C.L. (0000-0002-7008-4321)
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-09-01
Language
English
Is part of
International Journal of Radiation Oncology - Biology - Physics (2014), Vol. 90, p. S110-S111
hdl
1887/104598